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Under physiological conditions, microglia adopt a resting phenotype associated with
the production of anti-inflammatory and neurotrophic factors. In response to a wide
variety of insults, these cells shift to an activated phenotype that is necessary for the
proper restoration of brain homeostasis. However, when the intensity of a threat is
relatively high, microglial activation worsens the progression of damage rather than
providing protection, with potentially significant consequences for neuronal survival.
Coordinated interactions among microglia and other brain cells, including astrocytes and
neurons, are critical for the development of timely and optimal inflammatory responses
in the brain parenchyma. Tissue synchronization is in part mediated by connexins and
pannexins, which are protein families that form different plasma membrane channels
to communicate with neighboring cells. Gap junction channels (which are exclusively
formed by connexins in vertebrates) connect the cytoplasm of contacting cells to
coordinate electrical and metabolic coupling. Hemichannels (HCs) and pannexons
(which are formed by connexins and pannexins, respectively) communicate the intra-
and extracellular compartments and serve as diffusion pathways for the exchange of ions
and small molecules. In this review article, we discuss the available evidence concerning
the functional expression and regulation of connexin- and pannexin-based channels in
microglia and their contributions to microglial function and dysfunction. Specifically, we
focus on the possible implications of these channels in microglia-to-microglia, microglia-
to-astrocyte and neuron-to-microglia interactions in the inflamed brain.
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BACKGROUND
Microglia constitute approximately 5–15% of total cells in the central nervous system
(CNS) and are the major components of the innate immune system in the brain (Lawson
et al., 1990). Originating from myelomonocytic precursor cells (i.e., fetal macrophages)
derived from the hemangioblastic mesoderm, microglia populate the brain parenchyma
prior to the developmental closure of the blood-brain barrier (BBB; Ginhoux et al., 2010).
Under physiological conditions, microglia exhibit a ‘‘resting’’ surveillance state (ramified
morphology) that is associated with active environmental exploration and the continuous
search for exogenous or endogenous signals representing a brain threat (Streit, 2001;
Kettenmann et al., 2011). Microglia assume protagonistic roles that extend far beyond their
classic participation in inflammatory and immunological responses, such as the control of
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neuronal proliferation and differentiation and synaptic plasticity
and transmission (Wu et al., 2015). In particular, the fine
interactions between microglia and chemical synapses are
essential for the consolidation of neuronal circuits, thereby
expanding the current concept of the ‘‘tripartite synapse’’ into a
‘‘quad-partite synapse’’ (Schafer et al., 2013; Wake et al., 2013).
Once homeostatic balance is altered, the resting microglia
phenotype shifts to a reactive phenotype (phagocytic
morphology) involving alterations to different microglial
functions, such as proliferation, morphology, motility
and migration, proteostasis, phagocytosis and intercellular
communication (Hanisch, 2002; Block et al., 2007). This wide
array of changes is known as ‘‘microglial activation’’ and
involves large-scale and substantial activation depending
on the nature, intensity and duration of the stimulus
(Ransohoff and El Khoury, 2015). During intense challenges
and chronic brain damage, microglia become uncontrolled
sources of inflammatory mediators (e.g., cytokines and
free radicals) that cause neuronal damage rather than
exhibiting a repair-orientated activity profile (Block et al.,
2007). Although an efficient immune response is necessary
to resolve brain threats, under these circumstances,
dysfunctional microglia favor the recruitment of non-resident
brain cells involved in the innate and adaptive immune
responses, thereby intensifying brain injury (Waisman et al.,
2015).
GENERAL CONCEPTS CONCERNING
CONNEXINS AND PANNEXINS
Transitions and commitments towards distinct reactive
phenotypes require close synchronization and communication
among microglia (Salter and Beggs, 2014). In vertebrates, cell-
to-cell communication and coordination between neighboring
cells are in part mediated by gap junctions (Bennett et al.,
1991; Sáez et al., 2003). Gap junctions are aggregates of
intercellular channels termed gap junction channels (GJCs)
that facilitate direct but selective cytoplasmic continuity
between contacting cells to promote the exchange of ions
(allowing electrical coupling), metabolites (e.g., adenosine
diphosphate [ADP], glucose, lactate and glutamate) and
second messengers (e.g., cyclic adenosine monophosphate
[cAMP] and inositol trisphosphate [IP3]; Söhl et al.,
2005; Goodenough and Paul, 2009; Figure 1). A GJC
comprises the serial docking of two hemichannels (HCs),
one of each contributed by two adjacent cells. Each HC
consists of a six-fold ring of connexin monomers; thus,
these channels are also known as connexons (Figure 1).
Connexins are members of a highly conserved protein family
encoded by 21 genes in humans and 20 genes in mice with
orthologs in other vertebrate species (Abascal and Zardoya,
2012).
Although they have long been recognized as the building
blocks of GJCs, HCs are fundamental pathways for molecular
and ionic interchange between intracellular and extracellular
compartments (Sáez and Leybaert, 2014). In a pioneering study
by Paul et al. (1991), cytoplasmic injection of Xenopus oocytes
with connexin46 (Cx46) mRNA (a newly cloned member of
the connexin family at the time) caused the induction of non-
selective cation currents, depolarization and cell lysis in single
oocytes. This phenomenon was not observed after transfection
with other connexins, leading to the following rationale: open
HCs disturb ionic imbalance, resulting in the persistent loss
of membrane potential and subsequent cell death. Therefore,
HC openings were assumed to be incompatible with normal
cell life. However, this concept has been disproven in the
last two decades by groundbreaking findings (Cotrina et al.,
1998; Stout et al., 2002; Ye et al., 2003; Cherian et al., 2005;
Romanov et al., 2007; Tong et al., 2007; Anselmi et al., 2008;
Burra et al., 2010; Garré et al., 2010; Orellana et al., 2012a;
Stehberg et al., 2012; Chever et al., 2014; Roux et al., 2015).
According to current thinking, the physiological opening of
HCs is required for the release of paracrine substances into
the extracellular milieu (e.g., adenosine triphosphate [ATP],
glutamate, nicotinamide adenine dinucleotide [NAD+] and
prostaglandin E2 [PGE2]) and the uptake of small molecules and
ions up to ∼1–1.2 kDa in size (e.g., glucose, cyclic ADP-ribose
[cADPR] and Ca2+; Wang et al., 2013; Sáez and Leybaert, 2014;
Figure 1).
A family of chordate proteins homologous to the ‘‘innexins’’
(the gap junction proteins of invertebrates) was discovered more
than a decade ago (Panchin et al., 2000). This three-member
family was designated the ‘‘pannexins’’ (Panx1–3) due to their
ubiquitous presence in all eumetazoans with the exception of
echinoderms (Abascal and Zardoya, 2012; Bond and Naus, 2014;
Figure 1). Although pannexins form GJCs when overexpressed
in Xenopus oocytes (Bruzzone et al., 2003), it seems that
pannexins lose their ability to directly couple adjacent cells in
vivo (Sosinsky et al., 2011). The major function of pannexins
is form single membrane channels (the so-called pannexons)
similar to HCs that permit paracrine/autocrine signaling with
specific features among cells (Dahl, 2015).
In the nervous system, HCs and pannexons fulfill important
physiological functions, including ischemic tolerance (Lin et al.,
2008; Schock et al., 2008), the establishment of adhesive
interactions (Cotrina et al., 2008), fear memory consolidation
(Stehberg et al., 2012), synaptic transmission (Klaassen et al.,
2011; Prochnow et al., 2012; Ardiles et al., 2014; Chever et al.,
2014), electrical activity and oscillations (Moore et al., 2014;
Lopatárˇ et al., 2015; Roux et al., 2015), glucose sensing (Orellana
et al., 2012a), mast cell degranulation (Harcha et al., 2015),
chemoreception (Wenker et al., 2012), BBB permeability (De
Bock et al., 2011; Kaneko et al., 2015), colonic transit (McClain
et al., 2014), migration (Liu et al., 2010, 2012) and proliferation
(Wicki-Stordeur et al., 2012). In contrast, different pathological
scenarios modify the normal functions of HCs and pannexons,
thereby altering their opening and permeability properties and
contributing to the onset and progression of diverse brain
diseases (Orellana et al., 2012b, 2013a; Bosch and Kielian, 2014;
Shestopalov and Slepak, 2014; Takeuchi and Suzumura, 2014;
Decrock et al., 2015). Here, we review and discuss the available
evidence concerning the functional expression and regulation of
GJCs, HCs and pannexons in microglia and their contributions
to microglial function and dysfunction (Tables 1, 2).
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FIGURE 1 | Basic structure of channels formed by connexins, innexins and pannexins. Connexins, innexins and pannexins share similar membrane
topologies consisting of four α-helical transmembrane domains connected by two extracellular loops and one cytoplasmic loop; both the amino- and carboxy-termini
are intracellular. The relative positions of the extracellular loop cysteines (green balls) and glycosylated asparagines (blue branches) are also shown. Connexons or
innexons (also known as hemichannels (HCs)) are formed from connexins or innexins consisting of six subunits each. Pannexons are single membrane channels
composed of six pannexin subunits. Recently, a Panx2 band pattern more consistent with an octamer than a hexamer was observed in cross-linking studies and
native gels examining purified homomeric full-length and C-terminal truncation mutants (Ambrosi et al., 2010). Under resting conditions, HCs and pannexons remain
preferentially closed, but they are activated by diverse physiological and pathological conditions and represent a diffuse transmembrane route between the intra- and
extracellular milieu. HCs dock with one another to form functional cell-to-cell channels termed gap junction channels (GJCs). GJCs aggregate in well-known
anatomical structures called gap junctions to facilitate the intercellular exchange of metabolites, second messengers and ions.
GAP JUNCTION COUPLING AND ITS
IMPLICATIONS FOR MICROGLIAL
FUNCTIONS
Connexin expression among microglia depends heavily on
the context of their activation. Although connexin36 (Cx36)
and connexin32 (Cx32) are highly expressed in the resting
surveillance state (Parenti et al., 2002; Dobrenis et al., 2005;
Maezawa and Jin, 2010), Cx43 protein and messenger ribonucleic
acid (mRNA) expression is rarely detected under these
conditions (Eugenín et al., 2001; Martínez et al., 2002; Rouach
et al., 2002; Dobrenis et al., 2005; Garg et al., 2005; Hinkerohe
et al., 2005, 2010; Lee et al., 2005; Même et al., 2006; Shaikh et al.,
2012; Richter et al., 2014). When microglia shift from resting
to activated states in different pathological scenarios, connexin
expression increases, particularly connexin29 (Cx29; Moon et al.,
2010), Cx32 (Takeuchi et al., 2006; Maezawa and Jin, 2010; Moon
et al., 2010), Cx36 (Cepeda et al., 2015) and Cx43 (Eugenín
et al., 2001; Garg et al., 2005; Orellana et al., 2011b; Eugenin
et al., 2012; Sáez et al., 2013; Talaverón et al., 2014; Table 1).
In the first study to demonstrate this phenomenon, reported by
Eugenín et al. (2001), stab wound injury or treatment with tumor
necrosis factor alpha (TNF-α) plus interferon gamma (IFN-γ)
promoted microglial activation and strongly increased Cx43
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TABLE 1 | Regulation of connexin and pannexin expression in microglia.
Effector Protein levels mRNA levels Technique Reference
Cryotraumatic brain injury ↑Cx29↑Cx32 NT Immunohistochemistry Moon et al. (2010)
LPS ↑Cx32 NT Flow cytochemistry Takeuchi et al. (2006)
MeCP2 deficiency ↑Cx32 NE RT-PCR, Immunohistochemistry, Western blotting Maezawa and Jin (2010)
TNF-α ↑Cx32 NT Flow cytochemistry Takeuchi et al. (2006)
GM-CSF NE Cx36 NT Western blotting Dobrenis et al. (2005)
IFN-γ + TNF-α ↑Cx36 NT Western blotting Dobrenis et al. (2005)
LPS NT NE Cx36 RT-PCR Dobrenis et al. (2005)
Rasmussen encephalitis ↑Cx36 NT Immunohistochemistry Cepeda et al. (2015)
AGEs ↑Cx43 NT Western blotting Shaikh et al. (2012)
Amyloid β-peptide ↑Cx43 NT Western blotting Orellana et al. (2011b)
Brain stab wound ↑Cx43 NT Immunocytochemistry Eugenín et al. (2001)
Calcium ionophore ↑Cx43 ↑Cx43 Immunohistochemistry, Western blotting, RT-PCR Martínez et al. (2002)
Glioma NT NF Cx43 RT-PCR Richter et al. (2014)
GM-CSF NF Cx43 NT Western blotting Dobrenis et al. (2005)
HIV encephalitis ↑Cx43 NT Immunocytochemistry Eugenin et al. (2012)
LPS NF Cx43 NT Western blotting, Immunohistochemistry Même et al. (2006)
IFN-γ + TNF-α NF Cx43 NT Western blotting Dobrenis et al. (2005)
IFN-γ + TNF-α ↑Cx43 NT Immunocytochemistry, Western blotting Eugenín et al. (2001)
Peptidoglycan ↑Cx43 ↑Cx43 RT-PCR, Western blotting Garg et al. (2005)
Spinal cord injury NE Cx43 NT Immunohistochemistry Lee et al. (2005)
Restraint stress NE Cx43 NT Immunohistochemistry Orellana et al. (2015)
TNF-α ↑Cx43 NT Western blotting Shaikh et al. (2012)
TNF-α + ATP ↑Cx43 NT Western blotting Sáez et al. (2013)
TNF-α + IL-1β ↑Cx43 NT Western blotting Sáez et al. (2013)
TNF-α + IFN-γ ↑Cx43 NT Western blotting Sáez et al. (2013)
Transplantation of NPCs ↑Cx43 NT Immunohistochemistry Talaverón et al. (2014)
Amyloid β-peptide ↑Panx1 NT Western blotting Orellana et al. (2011b)
IFN-γ NT ↑Panx1 RT-PCR Shestopalov and Slepak (2014)
Prenatal nicotine and postnatal HFC diet NE Panx1 NT Immunohistochemistry Orellana et al. (2014)
Restraint stress NE Panx1 NT Immunohistochemistry Orellana et al. (2015)
Rasmussen encephalitis ↑Panx1 NT Immunohistochemistry Cepeda et al. (2015)
TNF-α + ATP ↑Panx1 NT Western blotting Sáez et al. (2013)
TNF-α + IL-1β ↑Panx1 NT Western blotting Sáez et al. (2013)
TNF-α + IFN-γ ↑Panx1 NT Western blotting Sáez et al. (2013)
NE, no effect; NT, not tested; NF, not found; LPS, lipopolysaccharide; Mecp2, methyl-CpG binding protein 2; TNF-α, tumor necrosis factor alpha; GM-CSF, granulocyte-
macrophage colony-stimulating factor; IFN-γ , interferon gamma; AGEs, advanced glycation end-products; HIV, human immunodeficiency virus; ATP, adenosine
triphosphate; IL-1β, interleukin-1 beta; NPCs, neural progenitor cells; HCF, high fat/cholesterol.
expression based on immunofluorescence and western blotting
analyses. Remarkably, TNF-α plus IFN-γ enabled microglial
communication via gap junctions based on dye coupling with
Lucifer yellow (LY). This phenomenon occurs in a Cx43-
dependent manner because microglia cultured from Cx43 knock-
out (KO) mice did not exhibit GJC up-regulation following
treatment with the same mixture of pro-inflammatory agents
(Eugenín et al., 2001). Similar findings involving advanced
glycation end-products (AGEs) and TNF-α were reported by
Shaikh et al. (2012) AGE treatment increased Cx43 expression
and the release of TNF-α in human microglial CHME-5 cells
via a mechanism dependent on activation of the receptor
for AGE (RAGE). Importantly, treatment with TNF-α for 6
h mimicked AGE-induced Cx43 expression, but also evoked
the development of direct microglia-to-microglia coupling and
HC opening. Therefore, the AGE-induced release of TNF-α
by microglia exerted autocrine/paracrine enhanced effects on
both GJC and HC functions (Shaikh et al., 2012; Table 2;
Figure 2).
Microglia are rapidly activated in response to tissue damage
(Davalos et al., 2005), which initiates the complex production
of cytokines and gliotransmitters (e.g., ATP/ADP) that act in
an autocrine/paracrine manner to specifically govern dynamic
changes in the microglial phenotype (Chakfe et al., 2002;
Inoue, 2002; Seo et al., 2008). Thus, these modulators are
not simple on/off switches that control microglial activation
but instead demonstrate synergism, cooperation and even
antagonism. This phenomenon is evident in the induction
of microglial coupling triggered by TNF-α, as previously
mentioned (Figure 2). In a study by Sáez et al. (2013),
ATP, IFN-γ or interleukin-6 (IL-6) accelerated, delayed or
prevented TNF-α-evoked LY coupling in cultured microglia,
respectively (Figure 1). Because oxidized ATP (P2X receptor
blocker), 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic
acid, BAPTA, Ca2+ chelator) and IL-1ra (IL-1β receptor
antagonist) prevented microglial coupling caused by TNF-α
plus ATP, increases in the intracellular free Ca2+ concentration
([Ca2+]i) induced via the activation of P2X receptors led
to the autocrine release of IL-1β and further upregulation
of GJC functions (Sáez et al., 2013; Figure 2). Consistent
with this line of thought, P2X receptor activation increases
[Ca2+]i in microglia (Ferrari et al., 1996) and promotes gap
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TABLE 2 | Regulation of connexin- and pannexin-based channels in microglia.
Effector Protein Effect on Effect on Technique Reference
involved gap junction hemichannel
channel /pannexon
LPS Cx32 NT ↑ Glutamate release Takeuchi et al. (2006, 2008)
TNF-α Cx32 NT ↑ Glutamate release Takeuchi et al. (2006)
MeCP2 deficiency Cx32 NT ↑ Glutamate release Maezawa and Jin (2010)
Amyloid β-peptide Cx43 NT ↑ Ethidium uptake/patch clamp Orellana et al. (2011b)
Brain stab wound Cx43 ↑ NT Lucifer yellow coupling Eugenín et al. (2001)
Brain stab wound NF NF NT Sulforhodamine 101 coupling/ Richter et al. (2014)
biocytin coupling
Brain stab wound NF NF NT Sulforhodamine 101 coupling/ Wasseff and Scherer (2014)
sulforhodamine B coupling
Calcium ionophore Cx43? ↑ NT Lucifer yellow coupling Martínez et al. (2002)
Calcium chelator Cx43? ↓ NT Lucifer yellow coupling Sáez et al. (2013)
cAMP Cx43? NE NT Lucifer yellow coupling Martínez et al. (2002)
CD38 downregulation Cx43 NT ↑ ATP release/Lucifer yellow uptake Ma et al. (2014)
cGMP Cx43? NE NT Lucifer yellow coupling Martínez et al. (2002)
Cx43(E2) Cx43? ↓ NT Lucifer yellow coupling Sáez et al. (2013)
Glioma NF NF NT Sulforhodamine 101 coupling/ Richter et al. (2014)
biocytin coupling
IL-6 Cx43? ↓ ↓ Lucifer yellow coupling, ethidium uptake Sáez et al. (2013)
Lanthanum Cx43? ↓ ↓ Lucifer yellow coupling, ethidium uptake Sáez et al. (2013)
LPS injection (i.p.) NF NF NT Sulforhodamine 101 coupling/ Wasseff and Scherer (2014)
sulforhodamine B coupling
oATP Cx43? ↓ NT Lucifer yellow coupling Sáez et al. (2013)
Peptidoglycan Cx43? ↑ NT Lucifer yellow coupling Garg et al. (2005)
PMA Cx43? ↓ NT Lucifer yellow coupling Martínez et al. (2002)
Prenatal nicotine and Cx43 NT NE Ethidium uptake Orellana et al. (2014)
postnatal HFC diet
Restraint stress Cx43 NT NE Ethidium uptake Orellana et al. (2015)
RyR blocker Cx43 NT ↑ ATP release/Lucifer yellow uptake Ma et al. (2014)
TNF-α Cx43? ↑ ↑ Lucifer yellow coupling, propidium uptake Shaikh et al. (2012)
TNF-α + ATP Cx43? ↑ NT Lucifer yellow coupling Sáez et al. (2013)
TNF-α + IL-1β Cx43? ↑ NT Lucifer yellow coupling Sáez et al. (2013)
TNF-α + IFN-γ Cx43? ↑ ↑ Lucifer yellow coupling, ethidium uptake Sáez et al. (2013)
TNF-α + IFN-γ + ATP Cx43? ↑ NT Lucifer yellow coupling Sáez et al. (2013)
10Panx1 Cx43? ↓ NT Lucifer yellow coupling Sáez et al. (2013)
Amyloid β-peptide Panx1 NT ↑ Ethidium uptake/patch clamp Orellana et al. (2011b)
ATP Panx1? NT ↑ Ethidium uptake/yopro uptake Bernier et al. (2012) and
Sáez et al. (2013)
LPS Panx1 NT ↑ Ethidium uptake/ATP release Orellana et al. (2013b)
Prenatal nicotine and Panx1 NT ↑ Ethidium uptake Orellana et al. (2014)
postnatal HFC diet
Restraint stress Panx1 NT ↑ Ethidium uptake Orellana et al. (2015)
TGF-β Panx1 NT ↓ Ethidium uptake Orellana et al. (2013b)
Zinc Panx1? NT ↑ ATP release Higashi et al. (2011)
NE, no effect; NT, not tested; NF, not found; LPS, lipopolysaccharide; Mecp2, methyl-CpG binding protein 2; TNF-α, tumor necrosis factor alpha; cAMP, cyclic adenosine
monophosphate; cGMP, cyclic guanosine monophosphate; IL-6, interleukin-6; oATP, oxidized adenosine triphosphate; PMA, phorbol-12-myristate-13-acetate; RyR,
ryanodine receptor; IFN-γ, interferon gamma; ATP, adenosine triphosphate; IL-1β, interleukin-1 beta; HCF, high fat/cholesterol; TGF-β, transforming growth factor beta.
junction communication (Martínez et al., 2002). In seminal
studies performed by Martínez et al. (2002), LY coupling
evoked by the Ca2+ ionophore 4Br-A23187 correlated with
elevated Cx43 protein and mRNA levels. Although the increase
in [Ca2+]i is a conserved mechanism to directly inhibit gap
junctions formed by several connexins (Peracchia, 2004), it is
unknown whether this phenomenon is unique to microglia
or the indirect result of downstream effectors of Ca2+
that regulate the sorting, synthesis and/or degradation of
Cx43 GJCs.
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FIGURE 2 | Regulation of connexin- and pannexin-based channels by cytokines released from activated microglia. Advanced glycation end-products
(AGEs) and lipopolysaccharide (LPS) stimulate the receptor for age (RAGE) and Toll-like receptor 4 (TLR4) receptors (1), respectively, resulting in activation of the
nuclear factor-κβ; (NF-κβ) pathway (2). This pathway induces the autocrine/paracrine release of tumor necrosis factor-α; (TNF-α), which acts upon its receptor TNFR1
(3) and leads to the activation of glutaminase and the further release of glutamate through Cx32 HCs (4). In parallel, NF-κβ signaling promotes the autocrine/paracrine
release of interleukin-1β; (IL-1β), which acts upon its receptor as well as accessory proteins (IL1RI and IL1RAcP; 5) and leads to the release of ATP through Cx43
HCs and Panx1 channels (CHs) via an unknown mechanism (6). Additionally, IL-1β signaling favors the opening of GJCs composed of Cx43.
The previously described microglial coupling not only
begins during cytokine treatment but is also initiated when
microglia are exposed to bacteria-derived agents (Table 2).
In studies in primary microglia performed a decade ago,
Staphylococcus aureus-derived peptidoglycan (PGN) increased
Cx43 mRNA and protein levels as measured by reverse
transcription polymerase chain reaction (RT-PCR), western
blotting and immunofluorescence analysis (Garg et al., 2005).
Notably, Cx43 upregulation was accompanied by the gap
junction-dependent spread of LY among microglia, and this
response was completely blunted by 18-α-glycyrrhetinic acid,
which is a well-known gap junction blocker (Garg et al.,
2005). Microglial coupling triggered by PGN relies on the
direct action of this molecule on pattern recognition receptors,
including CD14 and Toll-like receptor 2 (TLR2). Supporting
this notion, the direct activation of TLR2 upregulates Cx43
mRNA expression and functional communication through GJCs
in intestinal epithelial cells (Ey et al., 2009). Alternatively,
nuclear factor κB (NF-κB) and mitogen-activated protein kinase
(MAPK) signaling promote the autocrine/paracrine release of
cytokines and inflammatory mediators following PGN-induced
TLR2 activation (Akira et al., 2001), particularly TNF-α and
IL-1β, which are well known inducers of gap junction functions
in microglia (Eugenín et al., 2001; Shaikh et al., 2012; Sáez et al.,
2013).
Does functional gap junctional communication occur
between microglia and other brain cells? According to Dobrenis
et al. (2005) microglial cells possess the potential not only
to build functional gap junctions through Cx36 but also to
establish this type of communication with hippocampal neurons.
These authors observed Cx36 expression in microglia and the
presence of electrical coupling between microglia with low
unitary conductance (<20 pS) and very low voltage sensitivity,
which are properties of Cx36 GJCs but not other connexins
(Srinivas et al., 1999; Teubner et al., 2000). These heterocellular
interactions mediated by neuro-microglial gap junctions
demonstrate anatomical and functional correlations neural
progenitor cells (NPCs) isolated from the subventricular zone
(SVZ). Talaverón et al. (2014) identified gap junctions between
implanted NPCs and host microglia at the ultrastructural level
in animals lesioned by axotomy. In a follow-up study, NPCs
and microglia established functional gap junctions during co-
culture as measured by LY dye transfer (Talaverón et al., 2015).
Multiple connexins are likely involved in this phenomenon
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because both Cx45 and Cx43 are expressed in NPCs (Talaverón
et al., 2015), and both connexins have also been found in
microglia (Dobrenis et al., 2005; Higashi et al., 2011). Thus,
coupling between microglial cells and NPCs sustains the
reciprocal signaling necessary for the proper development
of neurogenic niches, including the SVZ (Talaverón et al.,
2015). Consistent with this view, microglia and NPCs exhibit
close spatial interactions in the SVZ neurogenic niche, and
their interplay affects microglial functions and NPC fate (e.g.,
proliferation, differentiation and survival; Mäkelä et al., 2010;
Mosher et al., 2012; Liu et al., 2013; Shigemoto-Mogami
et al., 2014). Alternatively, given that the conservation of
implanted NPCs depends on the immunomodulatory and
neuroprotective molecules released by microglia (Martino and
Pluchino, 2006), gap junction coupling among these cell types
has the potential to be critical for experimental neural cell
therapies that exert beneficial effects on recovery after brain
injury.
Recently, two independent groups questioned the existence
of functional microglial coupling ex vivo. Employing brain
slices derived from CX3CR1-EGFP mice, Wasseff and Scherer
(2014) failed to detect the transfer of sulforhodamine-B
(SR-B) between injected microglia and any other cell type,
including EGFP-positive microglia. Similar observations were
also reported for neocortex slices from an Alzheimer’s mouse
model and mice exposed to a single lipopolysaccharide (LPS)
injection (Wasseff and Scherer, 2014). Furthermore, control
microglia or microglia found within the glioma environment
and stab wound areas were not coupled by gap junctions
based on the transfer of biocytin or sulforhodamine101 (SR101;
Richter et al., 2014). Considering this controversy in light
of early experiments favoring in vitro microglial coupling
(Eugenín et al., 2001; Martínez et al., 2002; Garg et al.,
2005), one may question whether SR-B, biocytin or SR101 are
appropriate dyes to observe coupling among microglia. GJCs
formed by different connexins exhibit specific permeability
properties depending on the size, shape and charge of the
molecules (Harris, 2007). Most studies claiming functional
coupling among microglia were performed by microinjecting
LY (Eugenín et al., 2001; Martínez et al., 2002; Garg et al.,
2005; Shaikh et al., 2012; Sáez et al., 2013). Therefore, the
discrepancies surrounding functional coupling likely arise from
the different methods employed to assess functional gap junction
communication.
Activated microglia are the major antigen presenting cells
(APCs) in the CNS (Almolda et al., 2015). APCs take up antigens
and process them into proteolytic peptides to generate major
histocompatibility complexes (MHCs), which are located on the
cell surface and initiate a proper adaptive immune response
by activating CD4+ and CD8+ T cells (van Kasteren et al.,
2014). APC-induced T cell stimulation relies on a mechanism
involving the assembly of a specialized supramolecular structure
known as the immunological synapse. This structure engages
T cell receptors (TCRs) through MHC-peptide complexes on
APCs (Grakoui et al., 1999). In the pioneering work by Neijssen
et al. (2005), the transfer of small peptides (∼1.8 kDa) between
Cx43-transfected cells represents a new mechanism for antigen
cross-presentation between APCs and T cells. In this context,
dendritic cells (DCs), which are professional APCs, establish
functional GJCs among themselves and with T cells, thereby
contributing to antigen transfer and DC activation as well as
cross-presentation during T cell activation at the immunological
synapse (Matsue et al., 2006; Corvalán et al., 2007; Mendoza-
Naranjo et al., 2007, 2011; Elgueta et al., 2009). Whether gap
junctions are crucial for the hypothetical transfer of antigen
peptides among activated microglia or whether these channels
cross-present antigens to T cells remains an open question.
Microglia possess the majority of the machinery to cross-
present antigens. Indeed, microglia express MHCs and co-
stimulatory molecules following a wide range of brain injuries,
including LPS-induced inflammation, ischemia, axotomy and
experimental autoimmune encephalomyelitis (Almolda et al.,
2015).
FUNCTIONAL HEMICHANNELS AND
PANNEXONS IN MICROGLIA
To date, the functional expression of HCs in microglia has
been documented in different studies (Table 2). Pioneering
observations by Takeuchi et al. (2006) noted that Cx32 possesses
the ability to form functional HCs in microglia. TNF-α induces
microglial glutamate release through the opening of Cx32 HCs, a
response dramatically suppressed by a mimetic peptide against
Cx32 (32Gap27; Takeuchi et al., 2006; Figure 2). Moreover,
glutamate release strongly correlates with the number of Cx32
HCs available on the microglial cell surface, suggesting a possible
role for TNF-α in the sorting and/or trafficking of Cx32. The
TNF-α-induced release of glutamate via Cx32 HCs triggers
neuritic beading and neuronal death, as observed by phase
contrast microscopy and terminal deoxynucleotidyl transferase-
dUTP nick end labeling (TUNEL) analysis (Takeuchi et al.,
2006). Thus, the opening of glial cell HCs is detrimental for
normal neuronal functions. These findings were corroborated
by other groups who performed dye uptake experiments in
which TNF-α by itself induced HC opening in human microglial
CHME-5 cells (Shaikh et al., 2012). Similarly, TNF-α plus
IFN-γ evoked dye uptake in EOC20 microglial cells via a
mechanism sensitive to the pharmacological inhibition of HCs
and pannexons (Sáez et al., 2013). These findings, as well as
the observation that TNF-α plus IFN-γ increases the expression
of Cx43 and Panx1, favors a role for Cx43 HCs and Panx1
channels as major targets of inflammatory mediators (Sáez et al.,
2013).
Reinforcing the hypothesis that microglial Cx32 HCs are key
players in neurotoxicity, glutamate released via these protein
conduits was critical for the induction of neuronal damage
during brain ischemia (Takeuchi et al., 2008) and experimental
autoimmune encephalomyelitis (Shijie et al., 2009) in studies
from Suzumura’s group. Unfortunately, the involvement of
Cx32 HCs in these brain pathologies was deduced based
on the positive outcome of disease progression achieved by
carbenoxolone (CBX) administration (Takeuchi et al., 2008;
Shijie et al., 2009). CBX is a widely used gap junction blocker
that also inhibits Panx1 channels (∼5 µM) but does not
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distinguish between Panx1 channels and HCs at concentrations
above 50 µM (Bruzzone et al., 2005; D’hondt et al., 2009).
Therefore, it is premature to draw conclusions regarding the true
participation of microglial Cx32 HCs in the progression of brain
disorders in the studies described above. However, a recent study
substantiated the involvement of microglial Cx32 HCs in Rett
syndrome, which is a neurodevelopmental disorder that affects
young girls and is primarily caused by loss-of-function mutations
in the X-linked MECP2 encoding methyl-CpG-binding protein
2 (MeCP2; Chahrour and Zoghbi, 2007). In this study, MeCP2-
null microglia released large amounts of glutamate due to
increased production by glutaminase and increased release
through Cx32 HCs (Maezawa and Jin, 2010). Strikingly, the
Cx32 HC blockers 32Gap27 and 32Gap24 dramatically prevented
microglia-mediated dendritic atrophy and the reduction of
dendritic (MAP2 and Ac-TN) and postsynaptic protein density
(PSD95 and GRIP1) and the glutamate receptor subunits
NR1, GluR2/3, and GluR6/7 (Maezawa and Jin, 2010). Thus,
Cx32 HCs represent potential pharmacological targets for
therapies to counter the harmful effects linked to microglial
dysfunction and miscommunication with neurons during Rett
syndrome.
Microglia under a resting surveillance state express significant
levels of Panx1 (Higashi et al., 2011; Orellana et al., 2011b,
2014; Rigato et al., 2012; Sáez et al., 2013) but not Panx2
(Rigato et al., 2012). Similar to the observations with connexins,
Panx1 is upregulated in microglia stimulated with different pro-
inflammatory agents, including IFN-γ (Shestopalov and Slepak,
2014), amyloid-β peptide (Aβ; Orellana et al., 2011b), TNF-α
plus ATP (Sáez et al., 2013), TNF-α/IFN-γ (Sáez et al., 2013)
and TNF-α/IL-1β (Sáez et al., 2013). The functional expression
of pannexons in microglia is a relatively new discovery stemming
from studies in which Aβ induces dye uptake and macroscopic
currents in these cells (Orellana et al., 2011b). These responses
are inhibited by mimetic peptides and pharmacological blockers
against Panx1 channels (10panx1, E1b and probenecid) or Cx43
HCs (Gap26, Gap27 and Cx43E2), whereas microglial cultures
from Cx43-null mice are unaffected by Aβ treatment (Orellana
et al., 2011b). The currents recorded at negative holding
potentials (−60 mV) reveal unitary events with conductances
near ∼500 and ∼220 pS; these conductances do not differ
greatly from those observed for Panx1 channels and Cx43 HCs
(Contreras et al., 2003; Bao et al., 2004). Additionally, channel
opening correlates with microglial activation, increased surface
levels of Panx1 and Cx43, and the prominent release of glutamate
and ATP via a pathway sensitive to Panx1 channel and Cx43
HC blockers (Orellana et al., 2011b). Notably, N-methyl-D-
aspartate (NMDA) and P2X7 receptor activation triggered by
these gliotransmitters results in the opening of Panx1 channels
in neurons, resulting in detrimental consequences for neuronal
survival (Orellana et al., 2011b).
The question of whether microglial pannexons and/or HCs
indeed participate in the onset and progression of Alzheimer’s
disease (AD) remains unanswered. A recent study by Takeuchi
et al. (2011) described a possible role for microglial Cx32
HCs as major regulators of the brain damage observed in
AD. The BBB-permeable Cx32 HC blocker INI-0602 not only
ameliorated symptoms in two amyotrophic lateral sclerosis
(ALS) mouse models, but also improved memory deficits
in the APP/PS1 transgenic model of AD (Takeuchi et al.,
2011). Interestingly, INI-0602 successfully inhibited microglial
glutamate release in vivo, potentially implicating microglial HC-
dependent excitotoxicity in disease progression in ALS and
AD mouse models. Although INI-0602 reduces Cx32 HC-
mediated glutamate release in cultured microglia (Takeuchi
et al., 2011), it will be interesting to examine whether this
HC blocker maintains its specificity over other channels
in vivo. The functional detection of microglial HCs and/or
pannexons in brain slices derived from AD mouse models
using pharmacological (e.g., mimetic peptides) and molecular
(e.g., protein downregulation) approaches will fully elucidate the
involvement of these microglial channels in AD.
Recently, the opening of microglial pannexons was described
in mouse models of stress-related mental disorders, such as
anxiety and major depression. In dye uptake experiments, acute
and chronic restraint stress protocols activated microglial Panx1
channels in hippocampal slices, with chronic restraint stress
exerting the strongest effects on these channels (Orellana et al.,
2015). This response did not occur in hippocampal slices from
Panx1 null mice and was fully suppressed by NMDA and
P2X7 receptor blocking (Orellana et al., 2015). Restraint stress
also elicits the opening of astroglial and neuronal HCs and
the concomitant involvement of the Cx43 and Panx1 channel-
forming proteins in these responses, respectively (Orellana
et al., 2015). Interestingly, glutamate and ATP release is highly
promoted in hippocampal slices derived from mice subjected
to restraint stress, but this phenomenon is entirely blunted
after treatment with Panx1 channel, Cx43 HC and NMDA and
P2X7 receptor inhibitors (Orellana et al., 2015). The authors
proposed that chronic restraint stress might increase brain
levels of glucocorticoids (GCs), resulting in further activation
of the NMDA/P2X7 receptors in microglia and astrocytes.
Consistent with this idea, chronic stress triggers NMDA and
GG receptor-mediated microglial activation (Nair and Bonneau,
2006), whereas GC exposure primes cytokine release from
microglia ex vivo (Frank et al., 2007); the latter effect is a well-
known inducer of ATP and glutamate release through glial cell
HCs (Takeuchi et al., 2006; Avendaño et al., 2015). In summary,
HC opening alters brain concentrations of different transmitters
and thus represents an overlooked form of miscommunication
that modifies the proper function of neuronal circuits in people
suffering from stress-related mental disorders.
CROSSTALK BETWEEN ASTROCYTES
AND MICROGLIA REGULATES CONNEXIN
AND PANNEXIN-BASED CHANNELS
Microglia and astrocytes respond to brain injury with distinctive
spatial and temporal activation patterns and their crosstalk
appears to be critical for neuronal outcomes (Liu et al.,
2011). The release of gliotransmitters, cytokines and growth
factors represents the primary mechanism by which glial cells
communicate with one another and respond to neural activity
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(Färber and Kettenmann, 2006; Koizumi, 2010). Activated
microglia modulate connexin expression and functional GJC and
HC activity in astrocytes (Rouach et al., 2002; Faustmann et al.,
2003; Hinkerohe et al., 2005; Même et al., 2006; Retamal et al.,
2007a; Orellana et al., 2011a). Normally, astrocytes are strongly
coupled through gap junctions and express high levels of Cx43
(Giaume et al., 1991). However, when they are cultured with
resting microglia, Cx43 levels and dye coupling are obviously
reduced (Rouach et al., 2002) and potentiated by LPS (Même
et al., 2006). Interestingly, the above response is mimicked
with conditioned media (CM) harvested from microglia pre-
treated with LPS, implying soluble factors released by microglia
modulate astrocytes (Même et al., 2006). Indeed, studies
involving Enzyme-Linked ImmunoSorbent Assay (ELISA),
immunoneutralization and cytokine receptor blocking reported
that IL-1β and TNF-α are soluble factors affecting Cx43
expression and GJC functions in astrocytes (Même et al.,
2006). Importantly, the influence of microglia on the function
of astroglial connexins extends beyond gap junctions and
also impacts the opening of HCs. Astrocytes exposed to CM
from LPS-stimulated microglia or IL-1β plus TNF-α exhibit a
conspicuous increase in HC activity as determined from unitary
current conductance measurements and dye uptake experiments
(Retamal et al., 2007a). This effect occurs in parallel with
the inhibition of dye coupling; thus, both cytokines released
by microglia regulate gap junctions and HCs in an opposing
manner in astrocytes (Retamal et al., 2007a). Notably, p38
MAPK pathway inhibition completely reduces the dual influence
of microglia in astroglial connexin channels (Retamal et al.,
2007a). Supporting these findings, WIN and methanandamide,
which are two well-known cannabinoids that counteract p38
MAPK signaling (Carracedo et al., 2004), impede the LPS-
mediated release of IL-1β and TNF-α from microglia, thereby
limiting their control of astroglial connexins (Froger et al.,
2009).
Recently, factors released by astrocytes were shown to
counteract the immunomodulatory actions of LPS in microglia,
including ATP release (Orellana et al., 2013b). In a recent
study, LPS-stimulated microglia produced large amounts of
nitric oxide (NO), which was accompanied by a significant
increase in [Ca2+]i and ATP release (Orellana et al., 2013b;
Figure 3). These responses were effectively blocked by L-N6,
NS-398, SC-560 and SC 19220, which are selective inhibitors
of iNOS, cyclooxygenase-1 (COX1), cyclooxygenase-2 (COX2)
and the PGE2 receptor EP1, respectively (Orellana et al., 2013b).
Interestingly, LPS-induced ATP release was not detected after
blocking Panx1 channels with probenecid and 10panx1 or in
microglia treated with siRNA targeting Panx1 (Orellana et al.,
2013b). This peculiar pharmacology suggested a direct link
between LPS and Panx1 channel opening, which occurred
in response to NO production, COX activation and PGE2
release. Remarkably, Transforming growth factor beta 1 (TGF-
β1) release by activated astrocytes completely abolished the
LPS-induced increase in NO production, [Ca2+]i, ATP release
and Panx1-dependent dye uptake (Orellana et al., 2013b;
Figure 3). Moreover, the Panx1-dependent release of ATP and
subsequent activation of the P2Y1 and P2X7 receptors were
crucial for the preservation of LPS-mediated NO production
in microglia (Orellana et al., 2013b). Subsequent experiments
corroborated the connection between iNOS/COXs/EP1 receptor
signaling and the functional opening of Panx1 channels in
microglia. Prenatal nicotine exposure and a postnatal high-
fat/cholesterol diet after weaning increase the opening of
astroglial Cx43 HCs and Panx1 channels in microglia and
neurons (Orellana et al., 2014). The opening of microglial
pannexons is not paralleled by significant changes in Panx1
expression but is associated with the release of ATP via a
mechanism dependent on the activation of the iNOS/COX2/EP1
receptor pathway and signaling via P2X7 receptors (Orellana
et al., 2014).
How does the ATP released through microglial Panx1
channels contribute to cell-to-cell communication in the brain
parenchyma? ATP is a crucial transmitter involved in the
crosstalk between brain cells (Fields and Burnstock, 2006) and
has often been linked with the activation and chemotaxis-related
features of microglia (Honda et al., 2001). In the CNS, one
of the major signs driving microglia into an ‘‘activated’’ state
is a prominent rise in extracellular ATP levels, potentially in
response to tissue injury. Given this background, microglial
sensitivity to ATP relies on the expression of the two purinergic
receptor families: G-protein coupled-type P2 receptors (P2Y
receptors, P2YRs) and ionotropic P2 receptors (P2X receptors,
P2XRs; Inoue, 2002). Upon their activation, P2YRs/P2XRs
induce membrane ruffling and ramification of cultured microglia
(Nolte et al., 1996) as well as the release of different messengers
and signaling molecules, such as TNF-α and IL-1β (Inoue, 2002).
The majority of these paracrine mediators reinforce microglial
activation (Chao et al., 1995; Kuno et al., 2005) and lead to
the opening of microglial pannexons and HCs (Takeuchi et al.,
2006; Shaikh et al., 2012; Sáez et al., 2013). In leading-edge
studies by Davalos et al. (2005), extracellular ATP controlled
microglial chemotactic responses in the brain parenchyma;
moreover, its release from injured tissue (particularly astrocytes)
mediated a rapid microglial reaction towards the damage
site. Because CBX and flufenamic acid (nonspecific blockers
of HCs and pannexons) strongly inhibit microglial responses
towards a site of injury, both channels were suggested to
be major astroglial conduits for ATP release during rapid
microglial responses to local brain trauma (Davalos et al.,
2005). Although a great deal remains to be learned about
the events affecting the opening of HCs and/or pannexons
in microglia during brain trauma, this study demonstrated
a role for connexins and pannexins in microglial branch
dynamics.
Astrocytes are the primary partnering cells that share ATP-
mediated communication with microglia. Astrocytes release ATP
through Cx43 HCs and/or Panx1 channels (Cotrina et al., 1998;
Braet et al., 2003; Iglesias et al., 2009; Garré et al., 2010; Orellana
et al., 2011a,b; Suadicani et al., 2012), resulting in the activation
of P2XRs/P2YRs and the regenerative release of ATP via these
channels (Iglesias et al., 2009; Garré et al., 2010; Suadicani et al.,
2012). This mechanism of ATP-induced ATP release is critical
for the spread of Ca2+ waves (Guthrie et al., 1999; Anderson et al.,
2004) and constitutes a critical pathway through which astrocytes
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FIGURE 3 | Astroglial modulation of ATP-induced Ca2+ dynamics in LPS-stimulated microglia. After LPS stimulation, microglia respond with intracellular
signal transduction, leading to iNOS activation, nitric oxide (NO) production, cyclooxygenase (COX) activation and prostaglandin E2 (PGE2) production via unknown
mechanisms (1). PGE2 released by microglia binds to the EP1 metabotropic receptor (2) to induce Ca2+ release from intracellular stores (3). This release increases
[Ca2+]i, which is known to open Panx1 channels (CHs) and subsequently release ATP (4). ATP released via Panx1 CHs and its degradation to ADP activate P2Y1
receptors, which induce IP3 receptor activation and the further release of Ca2+ stored in the endoplasmic reticulum (5). Astrocytes stimulated with LPS release
transforming growth factor β1 (TGFβ1) (6), which inhibits LPS-induced intracellular signal transduction and causes iNOS activation. An alternative negative feedback
loop mediates the inhibitory effects of ATP on Panx1 channels (not depicted). Finally, paracrine release of ATP from microglia acts upon neighboring or distant
microglia, resulting in an additional feed-forward mechanism (not depicted).
exert their immunomodulatory actions over microglia (Verderio
and Matteoli, 2001; Schipke et al., 2002). Indeed, purinergic
receptors and the activation of HCs and pannexons represent
an essential mechanism for the maintenance of the regenerative
release of ATP in microglia because acute application of this
gliotransmitter induces the opening of Cx43 HCs and Panx1
channels in these cells (Bernier et al., 2012; Sáez et al., 2013).
How does ATP activate P2XRs in microglia? Extracellular ATP
produces different outcomes in terms of the P2XR-mediated
activation of macrophages and microglia depending on the
treatment period and concentration used (Baroja-Mazo et al.,
2013). For P2X7Rs, brief treatment with ATP stimulates small
cationic currents of 10–30 pS, whereas repetitive or long-
lasting application of ATP generates large currents of ∼440 pS
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and the rapid uptake of large molecules (up to 900 kDa).
Potentially, P2X7R conductance increases over time, resulting
in the formation of a large pore to facilitate the passage of
molecules; alternatively, P2X7Rs activates a second non-selective
permeability pathway (Baroja-Mazo et al., 2013). Panx1 channels
mediate P2X7R-dependent permeability for large molecules in
macrophages (Pelegrin and Surprenant, 2006) and microglia
(Bernier et al., 2012) but do not participate in microglial
P2X4R pore formation (Bernier et al., 2012). Coincident findings
related to the latter observation were recently described in
mouse peritoneal macrophages (Seil et al., 2010), and a Panx1-
independent model has been proposed for P2X2R large molecule
permeability (Chaumont and Khakh, 2008). Future studies will
elucidate the participation of Panx1 channels in the long-
lasting activation of other P2XRs in addition to P2X7Rs in
microglia.
P2X7R activation drives the release of ATP in microglia
via at least one mechanism involving HCs and/or pannexons.
Although P2X7R activation increases [Ca2+]i (Baroja-Mazo et al.,
2013) and opens Cx43 HCs and Panx1 channels (Locovei
et al., 2006b; De Vuyst et al., 2009; De Bock et al., 2012;
Wang et al., 2012), the Panx1-dependent release of ATP
relies on protein-protein interactions between P2X7Rs and
Panx1 (Locovei et al., 2007). Supporting this idea, Panx1 co-
immunoprecipitates with P2X7Rs (Pelegrin and Surprenant,
2006; Silverman et al., 2009; Li et al., 2011; Poornima et al.,
2012; Hung et al., 2013), and proline 451 in the C-terminal
tails of these receptors has been implicated in this interaction
(Iglesias et al., 2008; Sorge et al., 2012). P2YRs activation
constitutes a second mechanism by which ATP is released
from microglia. Because P2YRs mediate Ca2+ release from
intracellular stores, they induce HC/pannexon opening linked
to the consequential release of ATP from microglia, which was
previously demonstrated for other cell types (Locovei et al.,
2006a; Orellana et al., 2012a; Zhang et al., 2012). Although some
observations support exocytosis as the predominant route for
ATP release in microglia (Imura et al., 2013), Panx1 channels
and Cx43 HCs facilitate its release after stimulation with LPS
(Orellana et al., 2013b), Aβ (Orellana et al., 2013b) or ZnCl2
(Higashi et al., 2011).
Interestingly, P2X7R-dependent opening of Panx1 channels
has been linked to the secretion of IL-1β by a mechanism
involving the activation of the inflammasome (Pelegrin and
Surprenant, 2006, 2007, 2009; Kanneganti et al., 2007). During
an infection, innate immune cells recognize different pathogen-
associated molecular patterns (PAMPs) and damage-associated
molecular patterns (DAMPs) expressed and released by invading
pathogens and dying cells, respectively (Bianchi, 2007). Members
of the NOD-like receptor (NLR) family recognize PAMPs and
DAMPs and in association with the adaptor apoptosis speck-like
protein containing a CARD (ASC) constitute the inflammasome
platform (Martinon et al., 2002), which is critical for caspase-
1 activation, production of the IL-1β and proper host defense
response (Netea et al., 2010). ATP is a well-known DAMP
released from damaged or dying cells after trauma that promotes
inflammasome activation by acting at P2X7R (Ayna et al.,
2012). Protein-to-protein interaction between P2X7R and Panx1,
as well as increase in extracellular K+ stimulate Panx1 channel
opening, thus releasing more ATP into the extracellular space
(Pelegrin and Surprenant, 2006, 2007, 2009; Kanneganti et al.,
2007). In neurons and astrocytes, opening of Panx1 channels
leads to caspase-1 activation by a mechanism involving the
association of Panx1 with components of the multiprotein
inflammasome complex, including the P2X7R (Silverman et al.,
2009; Murphy et al., 2012; Minkiewicz et al., 2013). Although
IL-1β secretion in microglia depends on activation of the
inflammasome (Terada et al., 2010; Burm et al., 2015), whether
Panx1 channels participate in this process remain to be
elucidated.
In seminal studies by Bruzzone et al. (2001), Cx43 HCs
promoted cyclic ADP-ribose (cADPR) signaling by inducing the
release of NAD+. After cyclization of NAD+ by CD38, this
ectoenzyme produces cADPR, which is a potent endogenous
agonist of ryanodine receptors (RyRs) that serves as a universal
mobilizer of Ca2+ from intracellular stores (Malavasi et al.,
2008). Moreover, HCs not only mediate the outward passage
of NAD+ but also import cADPR into macrophages to activate
intracellular Ca2+ mobilization (Song et al., 2011). Interestingly,
CD38 plays a key role in the basal survival of microglia due
to its inhibitory effects on Cx43 HC-dependent ATP release
(Ma et al., 2014). Downregulation of CD38 or pharmacological
inhibition of RyRs increases ATP release, microglial activation
and death via a mechanism involving the opening of Cx43
HCs. Molecular (siRNA) and pharmacological inhibition of
Cx43 HCs dramatically ameliorates the decreased CD38/cADPR
signaling-induced release of ATP, NO production and apoptosis
by microglia (Ma et al., 2014). Cx43 HC opening and ATP
release are likely caused by the production of superoxide because
treatment with the broadly used antioxidant NAC strongly
attenuates RyR inhibition-mediated dye uptake in microglia (Ma
et al., 2014). Accordingly, oxidative stress opens Cx43 HCs in
astrocytes (Retamal et al., 2006) and HeLa Cx43 transfectants
(Retamal et al., 2007b). The Cx43 HC-dependent release of
ATP activates P2X7R, resulting in a mechanism of ATP-induced
ATP release that leads to microglial activation and cell death.
Although ATP-mediated HC opening has been linked to cell
death in neurons and astrocytes (Orellana et al., 2011a,b;
Rovegno et al., 2015), additional studies are required to fully
elucidate whether similar mechanisms result in microglial cell
death.
Together, this evidence supports the hypothesis that
regenerative Panx1/Cx43-dependent ATP release from
astrocytes and microglia relies on purinergic, CD38/cADPR and
Ca2+ signaling, resulting in further stimulation of neighboring
microglia (Fontainhas et al., 2011; Orellana et al., 2013b; Ma
et al., 2014). Thus, P2YR/P2XR activation is turned off in part
by ATP diffusion to distal regions as well as the desensitization
of these receptors and the degradation of extracellular ATP
by exonucleases (Fields and Burnstock, 2006). Similarly,
ATP directly inhibits Panx1 channels (Qiu and Dahl, 2009),
thereby constituting an alternative negative feedback loop in
the glial network. Another regulatory mechanism relies on
the inhibitory effects of the increase in [Ca2+]i over Cx43
HCs due to purinergic signaling activation. Accordingly,
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Cx43 HCs exhibit a biphasic and bell-shaped dependency
on [Ca2+]i (i.e., concentrations below 500 nM result in their
activation, whereas concentrations over 500 nM trigger a
negative feedback loop; De Vuyst et al., 2009; De Bock et al.,
2012; Wang et al., 2012). In the inflamed CNS, astrocytes
potentially suppress this self-perpetuating mechanism of
ATP release in microglia by secreting anti-inflammatory
factors such as TGF-β, as previously observed (Orellana et al.,
2013b).
PANNEXONS REGULATE MICROGLIAL
MIGRATION AND MORPHOLOGY
Based on a large body of evidence, neurons are an important
source of molecules that dictate the morphology, dynamic
behavior and chemotaxis of microglia (Ey et al., 2009; Domercq
et al., 2013). In particular, pannexons play a crucial role
in this crosstalk. According to Fontainhas et al. (2011), the
Panx1-dependent release of ATP in response to glutamatergic
neurotransmission increased dendritic morphology and process
dynamics in microglia in retinal explants. Notably, ATP-induced
microglial changes were observed even upon glutamatergic
blockade, whereas purinergic receptor inhibition decreased this
response despite glutamatergic stimulation, suggesting ATP
release occurs ‘‘downstream’’ of glutamate receptor activation
(Fontainhas et al., 2011). Although the identity of the cells
responsible for ATP release in the retina has not been reported,
possible candidates include astrocytes, Müller cells, neurons and
microglia themselves.
A recent study that performed in vivo time-lapse imaging
of both microglial morphology and neuronal activity in
the optic tectum of larval zebrafish revealed the crucial
role of Panx1 channels on tectal neurons in the dynamic
orientation of resting microglial processes (Li et al., 2013).
Membrane depolarization evoked large probenecid-sensitive
outward currents in tectal neurons but not in microglia.
Moreover, blockade of Panx1 channels with probenecid or CBX
significantly reduced the number of bulbous endings (microglial
processes that dynamically contact the neuronal soma; Li et al.,
2013). Acute treatment with the ATP-hydrolyzing enzyme
apyrase or the purinergic receptor blocker suramin strongly
reduced the percentage of bulbous endings, suggesting the
involvement of extracellular ATP and/or ADP in regulating the
baseline motility of resting microglial processes (Li et al., 2013).
ATP and purinergic signaling have been linked to microglial
migration towards distant lesions in leeches (Samuels et al.,
2010, 2013). In the leech, a single giant glial cell with structural
and functional features similar to mammalian astrocytes and
oligodendrocytes ensheathes axon tracts that connect neuronal
cell bodies (Deitmer et al., 1999). Apyrase and CBX inhibit the
ATP-dependent migration of microglia and their aggregation
at lesions (Samuels et al., 2013). The specific downregulation
of innexons (i.e., the pannexon homologs in non-chordates)
in the giant glia dramatically reduce dye efflux and microglial
migration, suggesting the requirement for innexon-dependent
release of ATP from glia for microglial chemotaxis at sites of
injury (Samuels et al., 2013). Although the question of whether
astroglial or neuronal pannexons exert differential influences
over microglial migration depending on the context of injury
remains open, purinergic signaling is clearly part of this process.
CONCLUSIONS AND FUTURE
DIRECTIONS
The functional state of HCs, pannexons and GJCs is finely
regulated during inflammation in microglial cells. In this
context, different PAMPs (e.g., AGEs, LPS) and DAMPs
(e.g., ATP) are recognized by microglial pattern recognition
receptors (PRRs), resulting in activation of the NF-κβ pathway
and the inflammasome complex. These pathways induce the
autocrine/paracrine release of pro-inflammatory cytokines (e.g.,
IL-1β and TNF-α), which activate the opening of connexin- and
pannexin-based channels and the release of ATP through Cx43
HCs and Panx1 channels.
Microglial activation is a highly dynamic and complex
process whose development is supported by the transfer of
messengers through GJCs and paracrine signaling via the
functional opening of HCs and pannexons. The passage of
molecules and ions likely relies on the activation of different
intracellular pathways based on the degree and stage of
microglial activation. Therefore, gap junction communication
reflects the ability of an activated microglial cell to recruit
resting microglia or to establish direct communication with
other cells in the CNS to favor cross-presentation at the
immune synapse or promote the repair of damaged tissue
(Figure 4). Alternatively, HC/pannexon opening sustains the
microglial chemotactic responses and dynamics necessary to
ensure proper microglial migration to injury sites. Although the
impact of the increased microglial GJC activity on neuronal
survival is unknown, the opening of microglial HCs and
pannexons certainly lead to neuronal damage (Figure 4). Most
studies suggest that the release of gliotransmitters (e.g., ATP,
glutamate) through Cx43/Cx32 HCs and Panx1 channels is
critical to induce neuronal death by a mechanism involving
the activation of NMDARs/P2X7Rs and Panx1 channels in
neurons. Thus, the prevention of HC- and pannexon-mediated
microglial activation represents an unexplored strategy to
prevent neuronal damage and death during neuroinflammation.
Future studies will elucidate the impact of this signaling
pathway in neurodegenerative diseases in vivo. The findings
discussed here strengthen the emerging concept that the
unregulated membrane permeability of HCs, pannexons and
GJCs contributes to microglial dysfunction. Thus, connexins as
well as pannexins represent potential and alternative targets for
therapeutic intervention in neuroinflammatory diseases.
CLINICAL RELEVANCE
Although the clinical impact of dysfunctional HCs and
pannexons in microglia is still unknown, gene mutations
and changes in expression or distribution of connexins and
pannexins have been implicated in the genesis and progression
of different diseases (Penuela et al., 2014; Retamal et al.,
2015; Bai, 2016). For instance, germline mutations in genes
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FIGURE 4 | The roles of microglial connexin- and pannexin-based channels in neurodegeneration. Under progressive inflammatory conditions, cytokine
production and redox imbalance increase the opening of HCs and pannexons in microglia, permitting the influx of Ca2+ (1) and its spread to neighboring cells
through GJCs (2). Hemichannel and pannexon opening in microglia favor the release of ATP (3), which diffuses through the extracellular space to activate membrane
purinergic (P2) receptors (4). Intercellular Ca2+ waves propagated via GJCs increase the [Ca2+]i in distant microglia (5), facilitating the release of glutamate through
microglial HCs/pannexons (6) and the further activation of neuronal n-methyl-d-aspartate (NMDA) receptors (7). P2 and NMDA receptor activation in neurons
increase the activity of neuronal Panx1 channels and Cx36 HCs, impairing the electrochemical and Ca2+ imbalance that results in cell death (8).
encoding Cx26, Cx30, Cx31, Cx32 and Cx43 are linked with
almost the half of all cases of inherited neurosensory deafness
(Martínez et al., 2009), whereas Cx32 and Cx47 mutations
are associated with X-linked Charcot–Marie–Tooth (Kleopa
et al., 2006) and Pelizaeus–Merzbacher-like (Bugiani et al.,
2006) diseases, respectively. In addition, mutations in Cx46
and Cx50 are connected with congenital cataracts (Gong
et al., 2007), whereas people with Cx43 mutations show the
developmental disorder oculodentodigital dysplasia (ODDD)
that in a few cases is accompanied by palmoplantar keratoderma
(Paznekas et al., 2009). Along with the diseases associated
with connexin gene mutations, there is another group of
pathologies that involve changes in the expression, assembly
state or localization of connexins and/or pannexins. The
loss of gap junctional communication in different human
cell-derived tumors arises as the most remarkable example
of connexin regulation during pathology (Jiang and Penuela,
2016). Another illustrative example is the relocalization
of Cx43 and gap junction modulation that participate in
arrhythmias and heart failure (Severs et al., 2008). In the
CNS, patients with temporal lobe epilepsy exhibit high
levels of Panx1 compared to normal people (Jiang et al.,
2013), whereas Cx43, Cx30, Cx36 behave similarly in rodent
models of epilepsy (Mylvaganam et al., 2014). In the same
context, cortical spreading depression associated to Cx36 and
Panx1 dysfunction has been linked to the pathophysiology
of migraine with aura (Sarrouilhe et al., 2014). Recently,
Cepeda et al. (2015) showed that brain samples from children
undergoing Rasmussen encephalitis exhibit an increased
expression of Panx1 and Cx36 in Iba-1-positive cells compared
to control conditions. These findings put to the forefront
the potential therapeutic role that could have connexin
and pannexin-derived channels in different neurological
disorders.
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One of the most interesting challenges in the connexin and
pannexin field is to develop molecular strategies to specifically
target the expression and/or function of GJCs, HCs and
pannexons. Currently, most pharmacological (e.g., drugs and
mimetic peptides) and molecular (e.g., siRNAS and KO mice)
tools in animals models do not allow the discrimination between
GJC vs. HC/pannexon function (Sáez and Leybaert, 2014).
However, recent clinical evidence suggests that these channels
could be highly exploitable for pharmacological intervention
or serve for genetic screening purposes. At clinical level, two
major interesting approaches have been used to modulate
connexin/pannexin expression or the channels themselves:
targeting transcription/translation (e.g., antisense approaches)
and peptidomimetic strategies (e.g., Gap26, Gap27, Peptide5,
Gap19 and ACT-1). In this context, nowadays there are four well-
known companies with human therapeutic focus on connexins
and pannexins: CoDa Therapeutics Inc. (USA and New Zeland),
FirstString Research (USA), Theranexus (France) and Zealand
Pharma (Denmark). A general patent search for ‘‘connexin’’ or
‘‘pannexin’’ at the US Patent and Trade-mark Office website
reveals more than 500 and 25 issued, respectively. Different drugs
and peptides designed to modulate GJC and/or HCs have shown
stronger therapeutic effects in different human pathological
conditions including venous leg ulcers, eye inflammation and
trauma, as well as glaucoma (Becker et al., 2016). Future studies
will open new horizons to unveil the multiple therapeutic
opportunities that are behind the function and regulation of
connexin and pannexin-based channels.
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